Is PTCH2 p.Pro900= (c.2700G>A) pathogenic?

PTCH2 p.Pro900= (c.2700G>A) is classified Likely benign in PTCH2 (ClinVar, Single submitter, 1 submitter; last evaluated 2024-06-17). Ultra-rare (popmax 0.0408%, amr); Associated with nevoid basal cell carcinoma syndrome.

What condition is associated with PTCH2 p.Pro900= (c.2700G>A)?

PTCH2 p.Pro900= (c.2700G>A) is associated with nevoid basal cell carcinoma syndrome (ClinVar).

How common is PTCH2 p.Pro900= (c.2700G>A) in the general population?

PTCH2 p.Pro900= (c.2700G>A) is ultra-rare (popmax 0.0408%, amr) (gnomAD).

PTCH2 p.Pro900=

c.2700G>A · rs200437527 · VCV1607003

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Rare

ultra-rare (popmax 0.0408%, amr)

Conditions

nevoid basal cell carcinoma syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -20	GERP -3.9
Overall
CADD	0.114	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0408% Admixed American · 24/58,812 alleles

Filtering AF 0.0281% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0239%

Overall 0.00263% 42/1,595,528 alleles · ultra-rare exomes 24/1,443,496 · genomes 18/152,032 · joint denominator

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.0408%	2,450
South Asian	0.00674%	14,839
East Asian	0.00224%	44,596
Finnishnot grpmax-eligible	0.00159%	62,734
European (non-Finnish)	0.000855%	116,903

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: PTCH2
Protein: p.Pro900=
Coding: c.2700G>A
MANE Select: NM_003738
dbSNP: rs200437527
Type: single nucleotide variant
Location: chr1:44826764 (GRCh38)
Gene constraint: LOEUF 0.895 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 79.25
Residue 900: the 'extracellular domain 2 (ecd2)' region

Full PTCH2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nevoid basal cell carcinoma syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

PTCH2 p.Pro900Leu Uncertain significance ★★ ⚠ same residue
PTCH2 c.2976+2T>C Uncertain significance ★★ same condition
PTCH2 c.526-2A>G Uncertain significance ★★ same condition
PTCH2 c.618-6C>A Uncertain significance ★★ same condition
PTCH2 p.Ala1052Thr Uncertain significance ★★ ⚠ same condition
PTCH2 p.Ala1090Val Uncertain significance ★★ ⚠ same condition
PTCH2 p.Ala203Val Uncertain significance ★★ same condition
PTCH2 p.Ala21Thr Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ptch2-p-pro900 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown